Engaging African American men as citizen scientists to validate a prostate cancer biomarker: Work-in-progress

13Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

Background: African American men (AAM) are underrepresented in prostate cancer (PCa) research despite known disparities. Screening with prostate-specific antigen (PSA) has low specificity for high-grade PCa leading to PCa over diagnosis. The Prostate Health Index (PHI) has higher specificity for lethal PCa but needs validation in AAM. Engaging AAM as citizen scientists (CSs) may improve participation of AAM in PCa research. Objectives: Assess feasibility of mobilizing CSs to recruit AAM as controls for PHI PCa validation biomarker study. Methods: We highlight social networks/assets of stakeholders, CSs curriculum development/implementation, and recruitment of healthy controls for PHI validation. Results and Lessons Learned: Eight CSs completed all training modules and 139 AAM were recruited. Challenges included equity in research leadership among multiple principal investigators (PIs) and coordinating CSs trainings. Conclusions: Engaging AAM CSs can support engaging/ recruiting AAM in PCa biomarker validation research. Equity among multiple stakeholders can be challenging, but proves beneficial in engaging AAM in research.

Cite

CITATION STYLE

APA

Watson, K. S., Henderson, V., Murray, M., Murphy, A. B., Levi, J. B., McDowell, T., … Winn, R. A. (2019). Engaging African American men as citizen scientists to validate a prostate cancer biomarker: Work-in-progress. Progress in Community Health Partnerships: Research, Education, and Action, 13, 103–112. https://doi.org/10.1353/cpr.2019.0043

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free